Aptamer-PEG-modified Fe3O4@Mn as a novel T1- and T2- dual-model MRI contrast agent targeting hypoxia-induced cancer stem cells
出版年份 2016 全文链接
标题
Aptamer-PEG-modified Fe3O4@Mn as a novel T1- and T2- dual-model MRI contrast agent targeting hypoxia-induced cancer stem cells
作者
关键词
-
出版物
Scientific Reports
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-12-15
DOI
10.1038/srep39245
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tumor microenvironment for cancer stem cells
- (2016) Kazuyoshi Kise et al. ADVANCED DRUG DELIVERY REVIEWS
- Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T 1 and T 2 dual-mode magnetic resonance imaging
- (2016) Myeong-Hoon Kim et al. BIOMATERIALS
- Polydopamine-based coordination nanocomplex for T1/T2 dual mode magnetic resonance imaging-guided chemo-photothermal synergistic therapy
- (2016) Yan Chen et al. BIOMATERIALS
- Dynamic regulation of stem cell specification and maintenance by hypoxia-inducible factors
- (2016) Gregg L. Semenza MOLECULAR ASPECTS OF MEDICINE
- Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival
- (2016) S Joshi et al. ONCOGENE
- Targeting hypoxic response for cancer therapy
- (2016) Elisa Paolicchi et al. Oncotarget
- Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation
- (2015) Yeh-Hsing Lao et al. ACS Nano
- Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models
- (2015) J. P. B. O'Connor et al. CANCER RESEARCH
- The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
- (2015) Vicki Plaks et al. Cell Stem Cell
- Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
- (2015) M. Antonia Busquets et al. International Journal of Nanomedicine
- Biocompatible Low-Retention Superparamagnetic Iron Oxide Nanoclusters as Contrast Agents for Magnetic Resonance Imaging of Liver Tumor
- (2015) Yushuang Wei et al. Journal of Biomedical Nanotechnology
- Cancer stem cells, cancer cell plasticity and radiation therapy
- (2015) Erina Vlashi et al. SEMINARS IN CANCER BIOLOGY
- Concise Review: Stem Cells in Pancreatic Cancer: From Concept to Translation
- (2015) Deepak Raj et al. STEM CELLS
- Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem Cells
- (2014) Xin Wang et al. ACS Nano
- T1 and T2 Dual-Mode MRI Contrast Agent for Enhancing Accuracy by Engineered Nanomaterials
- (2014) Tae-Hyun Shin et al. ACS Nano
- Qualification of a Noninvasive Magnetic Resonance Imaging Biomarker to Assess Tumor Oxygenation
- (2014) F. Colliez et al. CLINICAL CANCER RESEARCH
- The Meaning, Measurement and Modification of Hypoxia in the Laboratory and the Clinic
- (2014) E.M. Hammond et al. CLINICAL ONCOLOGY
- T1–T2 Dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes
- (2014) Agnieszka Szpak et al. JOURNAL OF NANOPARTICLE RESEARCH
- Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells
- (2013) Haitao Zhu et al. Cancer Cell International
- Contrast agents for MRI
- (2013) H. Shokrollahi Materials Science & Engineering C-Materials for Biological Applications
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
- (2013) Jerome Gilleron et al. NATURE BIOTECHNOLOGY
- Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer
- (2013) Eva Karamitopoulou Frontiers in Oncology
- A Synergistically EnhancedT1-T2Dual-Modal Contrast Agent
- (2012) Zijian Zhou et al. ADVANCED MATERIALS
- Development of hypoxia-sensitive Gd3+-based MRI contrast agents
- (2012) Shimpei Iwaki et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Super-resolution in magnetic resonance imaging: A review
- (2012) Eric Van Reeth et al. CONCEPTS IN MAGNETIC RESONANCE PART A
- Synthesis, characterization, cell imaging and anti-tumor activity of multifunctional nanoparticles
- (2012) Qiu-Yun Chen et al. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- Cancer metabolism: current perspectives and future directions
- (2012) C Muñoz-Pinedo et al. Cell Death & Disease
- Current Progress of RNA Aptamer-Based Therapeutics
- (2012) Jiehua Zhou et al. Frontiers in Genetics
- Theranostic Magnetic Nanoparticles
- (2011) Dongwon Yoo et al. ACCOUNTS OF CHEMICAL RESEARCH
- Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles
- (2011) Hong Yang et al. BIOMATERIALS
- Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
- (2011) Yin Wang et al. Cell Stem Cell
- Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2
- (2011) Mitsuhiro Suzuki INTERNATIONAL JOURNAL OF ONCOLOGY
- Hypoxia inducible factors in cancer stem cells
- (2010) J M Heddleston et al. BRITISH JOURNAL OF CANCER
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Cancer stem cells: mirage or reality?
- (2009) Piyush B Gupta et al. NATURE MEDICINE
- Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transport proteins of the ABC family and multidrug resistance of tumor cells
- (2008) A. A. Stavrovskaya et al. BIOCHEMISTRY-MOSCOW
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started